← Eichor
Study identifier: NCT06707441 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Thorax vs. Trauma Injury Severity Scores as Outcome Predictors in Chest Trauma

Condition: Chest Trauma  ·  Sponsor: Al-Nahrain University

PhaseN/A
Planned participants150
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to compare the predictive utility of the Thorax Trauma Severity Score (TTSS) and the Trauma and Injury Severity Score (TRISS) in determining outcomes among patients presenting with chest trauma to the emergency room. The main questions it aims to answer are: Does the TTSS provide a more accurate prediction of patient outcomes (e.g., mortality, ICU admission) than the TRISS? Are there specific patient subgroups where one score is more effective than the other? Participants will: Have their chest trauma severity assessed using both TTSS and TRISS during their emergency room admission. Have their clinical outcomes (e.g., mortality, ICU admission, length of hospital stay) monitored throughout their hospital stay.

This description comes directly from the study's public registry record.

Talk to the study team

Abdulillah R. Khamees  ·  +9647838571013  ·  allaabed987@ced.nahrainuniv.edu.iq

Always discuss trial participation with your own doctor first.

Locations (1)

College of Medicine - Al-Nahrain UniversityBaghdad, IraqRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06707441